Ameriprise’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.09M | Sell |
115,611
-4,453
| -4% | -$48.9K | ﹤0.01% | 3258 |
|
|
2025
Q4 | $1.49M | Sell |
120,064
-5,921
| -5% | -$78.7K | ﹤0.01% | 3155 |
|
|
2025
Q3 | $1.81M | Sell |
125,985
-7,196
| -5% | -$98.6K | ﹤0.01% | 3059 |
|
|
2025
Q2 | $1.63M | Sell |
133,181
-16,018
| -11% | -$233K | ﹤0.01% | 3052 |
|
|
2025
Q1 | $3.28M | Sell |
149,199
-9,650
| -6% | -$227K | ﹤0.01% | 2616 |
|
|
2024
Q4 | $3.6M | Sell |
158,849
-5,747
| -3% | -$125K | ﹤0.01% | 2588 |
|
|
2024
Q3 | $2.99M | Sell |
164,596
-19,605
| -11% | -$454K | ﹤0.01% | 2701 |
|
|
2024
Q2 | $5.37M | Buy |
184,201
+102,652
| +126% | +$3.04M | ﹤0.01% | 2250 |
|
|
2024
Q1 | $2.89M | Sell |
81,549
-11,273
| -12% | -$451K | ﹤0.01% | 2680 |
|
|
2023
Q4 | $4.11M | Buy |
92,822
+1,438
| +2% | +$56.6K | ﹤0.01% | 2494 |
|
|
2023
Q3 | $3.49M | Sell |
91,384
-1,458
| -2% | -$61.3K | ﹤0.01% | 2543 |
|
|
2023
Q2 | $3.82M | Sell |
92,842
-7,004
| -7% | -$337K | ﹤0.01% | 2540 |
|
|
2023
Q1 | $5.73M | Sell |
99,846
-1,561
| -2% | -$88K | ﹤0.01% | 2222 |
|
|
2022
Q4 | $5.69M | Sell |
101,407
-2,608
| -3% | -$133K | ﹤0.01% | 2194 |
|
|
2022
Q3 | $4.41M | Sell |
104,015
-4,505
| -4% | -$231K | ﹤0.01% | 2310 |
|
|
2022
Q2 | $5.86M | Sell |
108,520
-1,972
| -2% | -$118K | ﹤0.01% | 2157 |
|
|
2022
Q1 | $7.1M | Sell |
110,492
-579
| -0.5% | -$38.1K | ﹤0.01% | 2185 |
|
|
2021
Q4 | $7.44M | Sell |
111,071
-2,076
| -2% | -$140K | ﹤0.01% | 2200 |
|
|
2021
Q3 | $7.75M | Sell |
113,147
-9,636
| -8% | -$681K | ﹤0.01% | 2063 |
|
|
2021
Q2 | $8.38M | Sell |
122,783
-5,983
| -5% | -$423K | ﹤0.01% | 2074 |
|
|
2021
Q1 | $8.9M | Sell |
128,766
-2,767
| -2% | -$187K | ﹤0.01% | 1975 |
|
|
2020
Q4 | $8.54M | Sell |
131,533
-6,313
| -5% | -$340K | ﹤0.01% | 1861 |
|
|
2020
Q3 | $6.51M | Sell |
137,846
-13,253
| -9% | -$630K | ﹤0.01% | 1895 |
|
|
2020
Q2 | $7.1M | Sell |
151,099
-1,182
| -0.8% | -$58.1K | ﹤0.01% | 1803 |
|
|
2020
Q1 | $6.8M | Sell |
152,281
-11,830
| -7% | -$621K | ﹤0.01% | 1686 |
|
|
2019
Q4 | $9.56M | Sell |
164,111
-13,724
| -8% | -$817K | ﹤0.01% | 1778 |
|
|
2019
Q3 | $10.7M | Buy |
177,835
+6,745
| +4% | +$402K | ﹤0.01% | 1638 |
|
|
2019
Q2 | $9.55M | Sell |
171,090
-6,165
| -3% | -$317K | ﹤0.01% | 1775 |
|
|
2019
Q1 | $9.88M | Sell |
177,255
-3,581
| -2% | -$182K | ﹤0.01% | 1714 |
|
|
2018
Q4 | $8.15M | Sell |
180,836
-51,795
| -22% | -$2.84M | ﹤0.01% | 1763 |
|
|
2018
Q3 | $15.3M | Sell |
232,631
-46,663
| -17% | -$2.9M | 0.01% | 1528 |
|
|
2018
Q2 | $18M | Sell |
279,294
-147,621
| -35% | -$9.14M | 0.01% | 1256 |
|
|
2018
Q1 | $23.6M | Buy |
426,915
+8,848
| +2% | +$464K | 0.01% | 1028 |
|
|
2017
Q4 | $20M | Sell |
418,067
-4,802
| -1% | -$235K | 0.01% | 1068 |
|
|
2017
Q3 | $21.3M | Sell |
422,869
-12,124
| -3% | -$623K | 0.01% | 996 |
|
|
2017
Q2 | $23.7M | Buy |
434,993
+12,212
| +3% | +$583K | 0.01% | 915 |
|
|
2017
Q1 | $17.8M | Sell |
422,781
-24,121
| -5% | -$1.03M | 0.01% | 1091 |
|
|
2016
Q4 | $19.2M | Sell |
446,902
-66,738
| -13% | -$2.71M | 0.01% | 1024 |
|
|
2016
Q3 | $21.2M | Buy |
513,640
+18,742
| +4% | +$785K | 0.01% | 904 |
|
|
2016
Q2 | $19.7M | Buy |
494,898
+712
| +0.1% | +$25.6K | 0.01% | 911 |
|
|
2016
Q1 | $16.6M | Sell |
494,186
-54,822
| -10% | -$1.71M | 0.01% | 1035 |
|
|
2015
Q4 | $18.6M | Sell |
549,008
-19,504
| -3% | -$610K | 0.01% | 960 |
|
|
2015
Q3 | $16.9M | Sell |
568,512
-178,183
| -24% | -$5.57M | 0.01% | 1050 |
|
|
2015
Q2 | $20.6M | Sell |
746,695
-57,429
| -7% | -$1.53M | 0.01% | 993 |
|
|
2015
Q1 | $20.3M | Sell |
804,124
-51,950
| -6% | -$1.23M | 0.01% | 1002 |
|
|
2014
Q4 | $19M | Buy |
856,074
+212,045
| +33% | +$4.3M | 0.01% | 1000 |
|
|
2014
Q3 | $13.1M | Buy |
644,029
+318,949
| +98% | +$6.35M | 0.01% | 1242 |
|
|
2014
Q2 | $6.25M | Buy |
325,080
+8,538
| +3% | +$159K | ﹤0.01% | 1919 |
|
|
2014
Q1 | $5.95M | Buy |
316,542
+989
| +0.3% | +$19.1K | ﹤0.01% | 1901 |
|
|
2013
Q4 | $6.15M | Buy |
315,553
+114,725
| +57% | +$2.1M | ﹤0.01% | 1863 |
|
|
2013
Q3 | $3.3M | Buy |
200,828
+15,310
| +8% | +$246K | ﹤0.01% | 2199 |
|
|
2013
Q2 | $2.78M | Buy |
+185,518
| New | +$2.72M | ﹤0.01% | 2211 |
|
Other funds holding IART
RCMNY
PCMI
VPM
VCM
Ameriprise's IART Position: Q1 2026 in Review
Ameriprise reduced its Integra LifeSciences (IART) stake by 3.7% in Q1 2026, selling an estimated $48.9K and leaving 115,611 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #3258.
Ameriprise first reported a position in IART in Q2 2013 and has held it in 52 quarters since. The position peaked at $23.7M in Q2 2017. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- Ameriprise held 115,611 shares of Integra LifeSciences worth $1.09M as of Q1 2026.
- Ameriprise sold 4,453 Integra LifeSciences shares in Q1 2026, an estimated $48.9K.
- Integra LifeSciences made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3258 holding.
- Ameriprise first reported a position in Integra LifeSciences in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Integra LifeSciences position peaked at $23.7M in Q2 2017.
- 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.